Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Lapatinib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1460.00 | 1102.75 | 1.3240 | 1.3725 |
| MCF7 | Linsitinib | 0.031623 | uM | 10 | 1250.00 | 353.09 | 1363.00 | 1102.75 | 1.2360 | 1.2753 |
| MCF7 | 17-AAG | 10 | uM | 10 | 1250.00 | 353.09 | 357.00 | 1102.75 | 0.3237 | 0.0067 |
| MCF7 | Lapatinib | 0.1 | uM | 10 | 1250.00 | 353.09 | 1033.00 | 1102.75 | 0.9368 | 0.9220 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 1250.00 | 353.09 | 438.00 | 1102.75 | 0.3972 | 0.1402 |
| MCF7 | Linsitinib | 10 | uM | 10 | 1250.00 | 353.09 | 666.00 | 1102.75 | 0.6039 | 0.4714 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1058.00 | 1102.75 | 0.9594 | 0.9502 |
| MCF7 | Erlotinib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1160.00 | 1102.75 | 1.0519 | 1.0626 |
| MCF7 | Erlotinib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 1088.00 | 1102.75 | 0.9866 | 0.9837 |
| MCF7 | Erlotinib | 1 | uM | 10 | 1250.00 | 353.09 | 1268.00 | 1102.75 | 1.1499 | 1.1774 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1228.00 | 1102.75 | 1.1136 | 1.1353 | |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 963.00 | 1102.75 | 0.8733 | 0.8417 | |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 561.00 | 1102.75 | 0.5087 | 0.3255 |
| MCF7 | Linsitinib | 0.01 | uM | 10 | 1250.00 | 353.09 | 1276.00 | 1102.75 | 1.1571 | 1.1858 |
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 1250.00 | 353.09 | 1357.00 | 1102.75 | 1.2306 | 1.2692 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 1250.00 | 353.09 | 1302.00 | 1102.75 | 1.1807 | 1.2128 |
| MCF7 | 17-AAG | 1 | uM | 10 | 1250.00 | 353.09 | 342.00 | 1102.75 | 0.3101 | -0.0192 |
| MCF7 | Erlotinib | 0.1 | uM | 10 | 1250.00 | 353.09 | 1513.00 | 1102.75 | 1.3720 | 1.4246 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 1250.00 | 353.09 | 470.00 | 1102.75 | 0.4262 | 0.1902 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1204.00 | 1102.75 | 1.0918 | 1.1098 | |
| MCF7 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 968.00 | 1102.75 | 0.8778 | 0.8475 |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 1250.00 | 353.09 | 1065.00 | 1102.75 | 0.9658 | 0.9581 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1527.00 | 1102.75 | 1.3847 | 1.4382 | |
| MCF7 | Erlotinib | 10 | uM | 10 | 1250.00 | 353.09 | 1209.00 | 1102.75 | 1.0964 | 1.1152 |
| MCF7 | Erlotinib | 0.01 | uM | 10 | 1250.00 | 353.09 | 1281.00 | 1102.75 | 1.1616 | 1.1910 |